Survey on Asthma and It's Treatment Pattern in Brahmanbaria City, Bangladesh

Abstract

A solid foundation for assessing asthma management is provided by demographic analyses of asthma conditions and medication use in a community. The purpose of this study is to identify risk factors among patients in addition to the medical care recommended by doctors in the heart of Brahmanbaria, Bangladesh. Asthma sufferers' monotherapy and combination therapies are highlighted in this treatment section along with various therapeutic classes. This investigation was carried out in a number of notable secondary-level hospitals in the Brahmanbaria city. The patients were questioned regarding the duration of the illnesses they were suffering from, possible causes of asthma development, and prescription regimen. Extrinsic asthma affects 63% of individuals, while intrinsic asthma affects 37% of patients. It was discovered that 34 people smoke actively, 59 people smoke passively around their family, and 7 people smoke completely consciously. In the other hand, Patients who have had the condition for 6 to 12 months make up 43%. The majority of patients—56%—have complained of chest discomfort. 28% of people wheeze while breathing. Here are the total 100 patients where 15% have been prescribed salbutamol. Mostly prescribed monotherapy was given with LTRA in 23% of patients. 11% of patients have been prescribed inhaled corticosteroids budesonide. Loratadine was rarely used in 2% of patients. LTRA and Doxofylline combination had a prevalence of 31% which was the maximum. In the case of severe persistent asthma, 8% of patients had been prescribed formoterol ipratropium bromide and budesonide combination.